These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22354933)

  • 1. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs.
    Arslan F; Houtgraaf JH; Keogh B; Kazemi K; de Jong R; McCormack WJ; O'Neill LA; McGuirk P; Timmers L; Smeets MB; Akeroyd L; Reilly M; Pasterkamp G; de Kleijn DP
    Circ Cardiovasc Interv; 2012 Apr; 5(2):279-87. PubMed ID: 22354933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury.
    Farrar CA; Keogh B; McCormack W; O'Shaughnessy A; Parker A; Reilly M; Sacks SH
    FASEB J; 2012 Feb; 26(2):799-807. PubMed ID: 22042224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model.
    Khalil PN; Neuhof C; Huss R; Pollhammer M; Khalil MN; Neuhof H; Fritz H; Siebeck M
    Eur J Pharmacol; 2005 Dec; 528(1-3):124-31. PubMed ID: 16324693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sequential changes in myocardial thickness and thickening which occur during acute transmural infarction, infarct reperfusion and the resultant expression of reperfusion injury.
    Turschner O; D'hooge J; Dommke C; Claus P; Verbeken E; De Scheerder I; Bijnens B; Sutherland GR
    Eur Heart J; 2004 May; 25(9):794-803. PubMed ID: 15120891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
    Mersmann J; Berkels R; Zacharowski P; Tran N; Koch A; Iekushi K; Dimmeler S; Granja TF; Boehm O; Claycomb WC; Zacharowski K
    Crit Care Med; 2010 Mar; 38(3):903-9. PubMed ID: 20081527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation.
    Mersmann J; Habeck K; Latsch K; Zimmermann R; Jacoby C; Fischer JW; Hartmann C; Schrader J; Kirschning CJ; Zacharowski K
    Basic Res Cardiol; 2011 Jan; 106(1):89-98. PubMed ID: 20967453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury.
    Swartz MF; Halter JM; Fink GW; Pavone L; Zaitsev A; Lee HM; Steinberg JM; Lutz CJ; Sorsa T; Gatto LA; Landas S; Hare C; Nieman GF
    J Card Surg; 2006; 21(3):254-60. PubMed ID: 16684053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent cardioprotection of enkephalin analogue Eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion.
    Karlsson LO; Bergh N; Li L; Bissessar E; Bobrova I; Gross GJ; Akyürek LM; Grip L
    Eur J Pharmacol; 2012 Jan; 674(2-3):378-83. PubMed ID: 22119384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion.
    Mersmann J; Koch A; Tran N; Zimmermann R; Granja TF; Larmann J; Herzog C; Theilmeier G; Bornstein SR; Kirschning CJ; Zacharowski K
    Crit Care Med; 2010 Oct; 38(10):1927-32. PubMed ID: 20855990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
    Timmers L; Henriques JP; de Kleijn DP; Devries JH; Kemperman H; Steendijk P; Verlaan CW; Kerver M; Piek JJ; Doevendans PA; Pasterkamp G; Hoefer IE
    J Am Coll Cardiol; 2009 Feb; 53(6):501-10. PubMed ID: 19195607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the edge: targeting Toll-like receptor 2 in ischemia/reperfusion injury.
    Lepper PM; Bals R
    Circ Cardiovasc Interv; 2012 Apr; 5(2):146-9. PubMed ID: 22511737
    [No Abstract]   [Full Text] [Related]  

  • 17. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
    Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
    J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury.
    Roesner JP; Petzelbauer P; Koch A; Mersmann J; Zacharowski PA; Boehm O; Reingruber S; Pasteiner W; Mascher D; Wolzt M; Barthuber C; Nöldge-Schomburg GE; Scheeren TW; Zacharowski K
    Crit Care Med; 2007 Jul; 35(7):1730-5. PubMed ID: 17522584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A; Gondwe M; Nadar A
    Life Sci; 2004 Jul; 75(8):901-10. PubMed ID: 15193950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.